These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 34651395)

  • 1. Similarities and differences between multiple sclerosis and type 1 diabetes.
    Pozzilli V; Grasso EA; Tomassini V
    Diabetes Metab Res Rev; 2022 Jan; 38(1):e3505. PubMed ID: 34651395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.
    Tiberti C; Nenna R; Tromba V; Filardi T; Petrarca L; Silvestri F; Fassino V; Montuori M; Mancino E; Lenzi A; Midulla F; Costantino F; Morano S
    Acta Diabetol; 2023 Oct; 60(10):1301-1307. PubMed ID: 37171699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic.
    Salmi H; Heinonen S; Hästbacka J; Lääperi M; Rautiainen P; Miettinen PJ; Vapalahti O; Hepojoki J; Knip M
    Arch Dis Child; 2022 Feb; 107(2):180-185. PubMed ID: 34045208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 as a Trigger for Type 1 Diabetes.
    Wang Y; Guo H; Wang G; Zhai J; Du B
    J Clin Endocrinol Metab; 2023 Aug; 108(9):2176-2183. PubMed ID: 36950864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The co-occurrence of multiple sclerosis and type 1 diabetes: shared aetiologic features and clinical implication for MS aetiology.
    Tettey P; Simpson S; Taylor BV; van der Mei IA
    J Neurol Sci; 2015 Jan; 348(1-2):126-31. PubMed ID: 25480016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination.
    Zheng C; Kar I; Chen CK; Sau C; Woodson S; Serra A; Abboud H
    CNS Drugs; 2020 Sep; 34(9):879-896. PubMed ID: 32780300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis and COVID-19.
    Mares J; Hartung HP
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Sep; 164(3):217-225. PubMed ID: 32686774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DKA and new-onset type 1 diabetes in Brazilian children and adolescents during the COVID-19 pandemic.
    Luciano TM; Halah MP; Sarti MTA; Floriano VG; da Fonseca BAL; Del Roio Liberatore R; Antonini SR
    Arch Endocrinol Metab; 2022 Mar; 66(1):88-91. PubMed ID: 35029857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 1 diabetes and multiple sclerosis: A Danish population-based cohort study.
    Nielsen NM; Westergaard T; Frisch M; Rostgaard K; Wohlfahrt J; Koch-Henriksen N; Melbye M; Hjalgrim H
    Arch Neurol; 2006 Jul; 63(7):1001-4. PubMed ID: 16831970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronaviruses and their relationship with multiple sclerosis: is the prevalence of multiple sclerosis going to increase after the Covid-19 pandemia?
    Lima M; Aloizou AM; Siokas V; Bakirtzis C; Liampas I; Tsouris Z; Bogdanos DP; Baloyannis SJ; Dardiotis E
    Rev Neurosci; 2022 Oct; 33(7):703-720. PubMed ID: 35258237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of an Insulin-Requiring Hyperglycemic Syndrome in SARS-CoV-2-Infected Young Individuals: Is It Type 1 Diabetes?
    Pietropaolo M; Hotez P; Giannoukakis N
    Diabetes; 2022 Dec; 71(12):2656-2663. PubMed ID: 35293987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sclerosis, idiopathic dilated cardiomyopathy, and insulin-dependent diabetes mellitus: a common mechanism of irregular immune regulation.
    Deretzi G; Kountouras J; Zavos C; Giartza-Taxidou E; Koutlas E; Kiriazopoulou E; Tsiptsios I
    Neurologist; 2011 May; 17(3):172-5. PubMed ID: 21532390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell targeting therapies in MS patients during the SARS-CoV-2 pandemic - when immunosuppression meets infection?
    Mycko MP
    Neurol Neurochir Pol; 2020; 54(6):490-501. PubMed ID: 33073348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encephalopathy associated with COVID-19 in a patient with multiple sclerosis.
    Naser Moghadasi A
    J Neurovirol; 2020 Dec; 26(6):973-975. PubMed ID: 33118141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 in teriflunomide-treated patients with multiple sclerosis: A case report and literature review.
    Capone F; Motolese F; Luce T; Rossi M; Magliozzi A; Di Lazzaro V
    Mult Scler Relat Disord; 2021 Feb; 48():102734. PubMed ID: 33429305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab.
    Brill L; Rechtman A; Zveik O; Haham N; Oiknine-Djian E; Wolf DG; Levin N; Raposo C; Vaknin-Dembinsky A
    JAMA Neurol; 2021 Dec; 78(12):1510-1514. PubMed ID: 34554197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of type 1 diabetes during the SARS-CoV-2 pandemic: Does lockdown affect the incidence and clinical status of patients?
    Zubkiewicz-Kucharska A; Seifert M; Stępkowski M; Noczyńska A
    Adv Clin Exp Med; 2021 Feb; 30(2):127-134. PubMed ID: 33599404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis.
    Ristori G; Faustman D; Matarese G; Romano S; Salvetti M
    Curr Opin Immunol; 2018 Dec; 55():89-96. PubMed ID: 30447407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal T-cell reactivities in childhood inflammatory demyelinating disease and type 1 diabetes.
    Banwell B; Bar-Or A; Cheung R; Kennedy J; Krupp LB; Becker DJ; Dosch HM;
    Ann Neurol; 2008 Jan; 63(1):98-111. PubMed ID: 17932975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MS and COVID-19 challenge: asymptomatic COVID-19 infection during treatment with cladribine.
    Seferoğlu M; Ethemoğlu Ö; Turan ÖF; Siva A
    Neurol Sci; 2021 Sep; 42(9):3533-3535. PubMed ID: 34165650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.